Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.24
-0.0550-4.26%
Post-market: 1.240.00000.00%17:01 EDT
Volume:274.19K
Turnover:337.43K
Market Cap:73.44M
PE:-0.34
High:1.28
Open:1.27
Low:1.19
Close:1.29
Loading ...

IGM Biosciences Faces Uncertainty Amid Cash Preservation and Restructuring Efforts

TIPRANKS
·
08 Mar

IGM Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
08 Mar

Morgan Stanley Sticks to Their Sell Rating for IGM Biosciences (IGMS)

TIPRANKS
·
07 Mar

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)

TIPRANKS
·
07 Mar

BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks
·
04 Mar

IGM Biosciences Inc expected to post a loss of 74 cents a share - Earnings Preview

Reuters
·
03 Mar

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks
·
27 Feb

Promising US Penny Stocks To Watch In February 2025

Simply Wall St.
·
19 Feb

Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround

Zacks
·
05 Feb

IGM Biosciences Raised to Neutral From Underweight by JP Morgan

Dow Jones
·
14 Jan

JPMorgan Upgrades IGM Biosciences to Neutral From Underweight

MT Newswires Live
·
13 Jan

U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40

Reuters
·
13 Jan

IGM Biosciences Inc : JP Morgan Raises to Neutral From Underweight

THOMSON REUTERS
·
13 Jan

IGM Biosciences upgraded to Neutral from Underweight at JPMorgan

TIPRANKS
·
11 Jan

IGM Biosciences Halts Antibody Therapies, Cuts Workforce

TIPRANKS
·
11 Jan

BUZZ-IGM Bio hits record low after development of two autoimmune drugs halted

Reuters
·
11 Jan